Seminars in Nuclear Medicine
Volume 32, Issue 3 , Pages 217-219 , July 2002

Transient adrenal gland uptake of gallium during septicemia

  • Lawrence Parker

      Affiliations

    • Endocrinology Section, Department of Veterans Affairs Medical Center, Long Beach, CA. USA
    • Cancer Program, Department of Veterans Affairs Medical Center, Long Beach, CA. USA
    • Molecular and Diagnostic Health Care Group, Department of Veterans Affairs Medical Center, Long Beach, CA. USA
    • Corresponding Author InformationAddress reprint requests to Lawrence Parker, MD, Endocrinology Section, Department of Veterans Affairs Medical Center, 5901 E 7th St, Long Beach, CA 90822.
    • ,
  • Edgar Moran

      Affiliations

    • Endocrinology Section, Department of Veterans Affairs Medical Center, Long Beach, CA. USA
    • Cancer Program, Department of Veterans Affairs Medical Center, Long Beach, CA. USA
    • Molecular and Diagnostic Health Care Group, Department of Veterans Affairs Medical Center, Long Beach, CA. USA
    • ,
  • Sing-Yung Wu

      Affiliations

    • Endocrinology Section, Department of Veterans Affairs Medical Center, Long Beach, CA. USA
    • Cancer Program, Department of Veterans Affairs Medical Center, Long Beach, CA. USA
    • Molecular and Diagnostic Health Care Group, Department of Veterans Affairs Medical Center, Long Beach, CA. USA

References 

  1. Wu S-Y. Gallium imaging. In: Baum S editors. Atlas of Nuclear Imaging. New York, NY: Appleton-Century-Crofts; 1991;p. 315–338
  2. Neumann RD, Hoffer PB. Gallium-67 scintigraphy for detection of inflammation and tumors. In: Freeman LM editors. Freeman and Johnson's Clinical Radionuclide Imaging. ed 3. Philadelphia, PA: Grune & Stratton; 1984;p. 1319–1364
  3. Lorberboym M, Sarkar SD, Speiser P, et al. Bilateral adrenal uptake of gallium-67 citrate in a patient with congenital adrenal hyperplasia. Clin Nucl Med. 1989;14:849
  4. Handmaker H, O'Mara RE. Gallium imaging in pediatrics. J Nucl Med. 1977;18:1057–1063
  5. Jackson JA, Naul LG, Montgomery JL, et al. Gallium-67 uptake by a benign adrenocortical adenoma. J Nucl Med. 1988;29:1451–1453
  6. Ward FT, Anderson JH, Jelinek J, et al. Localization of metastatic adrenal cortical carcinoma with Ga-67. Clin Nucl Med. 1991;16:117–119
  7. Howman-Giles R, Pozza LD, Uren R. Ga-67 scintigraphy in a child with adrenocortical carcinoma. Clin Nucl Med. 1993;18:642–645
  8. Dawson J, Harding LK. Phaeochromocytoma presenting as pyrexia of undetermined origin: Diagnosis using gallium-67. Br Med J. 1982;284:1164
  9. Hoshi H, Jinnouchi S, Ono S, et al. Scintigraphic demonstration of coexisting adenoma and metastasis of the adrenal gland in a patient with bronchogenic carcinoma. Clin Nucl Med. 1984;9:717–718
  10. Gumbinas M, Gratz ES, Johnston GS, et al. Positive gallium scan in the syndrome of opsoclonus-myoclonus treated with adrenocorticotropic hormone. Cancer. 1984;54:815–816
  11. Alazraki NP. Gallium-67 imaging in infection. In: Early PJ, Sodee DB editor. Principles and Practice of Nuclear Medicine. St Louis, MO: Mosby; 1995;p. 702–713
  12. Fawcett DW. Adrenal glands. In: Fawcett DW editors. A Textbook of Histology. New York, NY: Chapman & Hall; 1994;p. 508–512
  13. Bornstein SR, Chrousos GP. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: Neural and immune inputs. J Clin Endocrinol Metab. 1999;84:1729–1736
  14. Wolkersdorfer GW, Lohmann T, Marx C, et al. Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: A novel mechanism of immune-endocrine interaction. J Clin Endocrinol Metab. 1999;84:4220–4227
  15. Bacher M, Meinhardt A, Lan HY, et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol. 1997;150:235–246
  16. Maier R, Staehelin M. Adrenal responses to corticotrophin in the presence of an inhibitor of protein synthesis. Acta Endocrinol. 1968;58:619–629
  17. Lorberboym M, Rubin P, Warner R, et al. Adrenal glands imaging with indium-111-DTPA-D-Phe-octreotide following ACTH therapy. J Nucl Med. 1997;38:1489–1491

PII: S0001-2998(02)80008-3

doi: 10.1053/snuc.2002.126035

Seminars in Nuclear Medicine
Volume 32, Issue 3 , Pages 217-219 , July 2002

Article Tools